2026 ICD-10-CM Diagnosis Code D01.7Carcinoma in situ of other specified digestive organs

ICD-10-CM CodesC00–D49D00-D09D01

ICD-10-CM D01.7
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D01.7 is a billable ICD-10-CM diagnosis code for carcinoma in situ of other specified digestive organs. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 374 through 376. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Gastrointestinal cancers - all other types.

Code Identity

ICD-10-CM Code
D01.7
Billable Status
Yes — Valid for Submission
Code Describes
Carcinoma in situ of other specified digestive organs
Short Description
Carcinoma in situ of other specified digestive organs
Same as the full description in the CMS dataset.
Parent Code
Carcinoma in situ of other and unspecified digestive organs

Code Classification

ChapterC00–D49Neoplasms
SectionD00-D09In situ neoplasms
CategoryD01Carcinoma in situ of other and unspecified digestive organs
This CodeD01.7Carcinoma in situ of other specified digestive organs

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Carcinoma in situ of body of pancreas
  • Carcinoma in situ of endocrine gland
  • Carcinoma in situ of head of pancreas
  • Carcinoma in situ of islets of Langerhans
  • Carcinoma in situ of pancreas
  • Carcinoma in situ of pancreatic duct
  • Carcinoma in situ of spleen
  • Carcinoma in situ of tail of pancreas
  • Intraductal papillary mucinous carcinoma in situ of pancreas
  • Intraductal papillary mucinous neoplasm of pancreas
  • Neoplasm of body of pancreas
  • Neoplasm of head of pancreas
  • Neoplasm of tail of pancreas

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Carcinoma in situ of pancreas

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO021
Gastrointestinal cancers - all other types
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Carcinoma, Pancreatic Ductal

    carcinoma that arises from the pancreatic ducts. it accounts for the majority of cancers derived from the pancreas.
  • Cystic Fibrosis

    an autosomal recessive genetic disease of the exocrine glands. it is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator expressed in several organs including the lung, the pancreas, the biliary system, and the sweat glands. cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in airway obstruction; chronic respiratory infections; pancreatic insufficiency; maldigestion; salt depletion; and heat prostration.
  • Insulin Infusion Systems

    portable or implantable devices for infusion of insulin. includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
  • Islets of Langerhans

    irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the pancreas among the exocrine acini. each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. there are four major cell types. the most abundant beta cells (50-80%) secrete insulin. alpha cells (5-20%) secrete glucagon. pp cells (10-35%) secrete pancreatic polypeptide. delta cells (~5%) secrete somatostatin.
  • Nesidioblastosis

    an inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the pancreas and congenital hyperinsulinism. it is due to focal hyperplasia of pancreatic islet cells budding off from the ductal structures and forming new islets of langerhans. mutations in the islet cells involve the potassium channel gene kcnj11 or the atp-binding cassette transporter gene abcc8, both on chromosome 11.
  • Pancreas

    a nodular organ in the abdomen that contains a mixture of endocrine glands and exocrine glands. the small endocrine portion consists of the islets of langerhans secreting a number of hormones into the blood stream. the large exocrine portion (exocrine pancreas) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the duodenum.
  • Pancreas Divisum

    anatomic variants in pancreatic ducts characterized by failure of fusion of the ventral and dorsal endodermal buds. pancreas divisum results in inadequate or no communication between dorsal and ventral ducts. while most cases are asymptomatic, it may be associated with recurrent pancreatitis.
  • Pancreas Transplantation

    the transference of a pancreas from one human or animal to another.
  • Pancreas, Artificial

    devices for simulating the activity of the pancreas. they can be either electromechanical, consisting of a glucose sensor, computer, and insulin pump or bioartificial, consisting of isolated islets of langerhans in an artificial membrane.
  • Pancreas, Exocrine

    the major component (about 80%) of the pancreas composed of acinar functional units of tubular and spherical cells. the acinar cells synthesize and secrete several digestive enzymes such as trypsinogen; lipase; amylase; and ribonuclease. secretion from the exocrine pancreas drains into the pancreatic ductal system and empties into the duodenum.
  • Pancreatic Neoplasms

    tumors or cancer of the pancreas. depending on the types of islet cells present in the tumors, various hormones can be secreted: glucagon from pancreatic alpha cells; insulin from pancreatic beta cells; and somatostatin from the somatostatin-secreting cells. most are malignant except the insulin-producing tumors (insulinoma).
  • Pancrelipase

    a preparation of hog pancreatic enzymes standardized for lipase content.
  • Shwachman-Diamond Syndrome

    an inherited syndrome characterized by exocrine pancreatic insufficiency; hematologic abnormalities (e.g., bone marrow hypoplasia), and skeletal abnormalities (e.g., metaphyseal chondroplasia). germline mutations in the sbds gene are associated with shwachman-diamond syndrome.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
insular tissue (pancreas)C25.4C78.89D01.7D13.7D37.8D49.0
islands or islets of LangerhansC25.4C78.89D01.7D13.7D37.8D49.0
Langerhans, islands or isletsC25.4C78.89D01.7D13.7D37.8D49.0
pancreasC25.9C78.89D01.7D13.6D37.8D49.0
pancreas bodyC25.1C78.89D01.7D13.6D37.8D49.0
pancreas duct (of Santorini) (of Wirsung)C25.3C78.89D01.7D13.6D37.8D49.0
pancreas headC25.0C78.89D01.7D13.6D37.8D49.0
pancreas islet cellsC25.4C78.89D01.7D13.7D37.8D49.0
pancreas neckC25.7C78.89D01.7D13.6D37.8D49.0
pancreas tailC25.2C78.89D01.7D13.6D37.8D49.0
Santorini's ductC25.3C78.89D01.7D13.6D37.8D49.0
spleen, splenic NECC26.1C78.89D01.7D13.99D37.8D49.0
Wirsung's ductC25.3C78.89D01.7D13.6D37.8D49.0

Patient EducationClinical

Cancer

Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.

The full article covers:

  • What is cancer?
  • What are the types of cancer?
  • How does cancer develop?
  • What are the symptoms of cancer?
  • How is cancer diagnosed?
  • What are the treatments for cancer?
  • Can cancer be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D01.7 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
230.9 Ca in situ GI NEC/NOS
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D01.7Overview

Is D01.7 (Carcinoma in situ of other and unspecified digestive organs) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report carcinoma in situ of other specified digestive organs on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D01.7 group to?

When carcinoma in situ of other specified digestive organs is the principal diagnosis on an inpatient stay, it groups to MS-DRG 374, 375, 376, with relative weights from 0.9243 to 2.1387 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D01.7?

Under the General Equivalence Mappings, carcinoma in situ of other specified digestive organs converts to ICD-9-CM 230.9 (ca in situ GI NEC/NOS). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.